CERTIFICATE LIBRARY · BATCH-6021
Tirzepatide 60 MG
Batch BATCH-6021, tested by Kovera Labs and certified 2026-08-01. Every figure below is the value returned for this batch — not a target, and not another batch’s result.
99.579%PURITY · SPEC > 98%
| TEST | SPECIFICATION | RESULT | STATUS |
|---|---|---|---|
| Purity | > 98% | 99.579% | PASS |
| Net content | ~ 60 MG | 62.49 mg | PASS |
| Identity (LC-MS) | Tirzepatide | Confirmed | PASS |
| Endotoxin | ≤ 0.5 EU/mL | Pass | PASS |
| Sterility | No growth | No Growth | PASS |
| Heavy metal — Arsenic | Not detected | Negative | PASS |
| Heavy metal — Cadmium | Not detected | Negative | PASS |
| Heavy metal — Lead | Not detected | Negative | PASS |
| Heavy metal — Mercury | Not detected | Negative | PASS |
CHROMATOGRAM · RP-HPLC · C18 · DAD @ 214 nm
- BATCH
- BATCH-6021
- FILL
- 60 MG · SKU T60
- FORM
- Tirzepatide, lyophilized
- LABORATORY
- Kovera Labs
- REPORT NUMBER
- KVR-2026-D1E014-S496
- ACCESS CODE
- GFDMCB2
- CERTIFIED
- 2026-08-01
Verify this certificate independently at koveralabs.com/verify using report number KVR-2026-D1E014-S496 and access code GFDMCB2. We publish the code precisely so you do not have to take our word for any of this.